Form 4 for WST West Pharmaceutical Services
Accepted 2026-04-29 12:22:22 ET · period of report 2026-04-27 · accession 0000105770-26-000054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-29 12:22 | 2026-04-27 | WST | Favorite Annette F | SVP, Chief HR Off | M - OptEx | $83.47 | +2,817 | 19.6K | +17% | +$235.1K |
| D | 2026-04-29 12:22 | 2026-04-27 | WST | Favorite Annette F | SVP, Chief HR Off | S - Sale+OE | $305.20 | -2,817 | 16.8K | -14% | -$859.8K |
| D | 2026-04-29 12:22 | 2026-04-27 | WST | Favorite Annette F | SVP, Chief HR Off | M - OptEx | $0.00 | -2,817 | 5,635 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-27 | M | A | 2,817 | $83.47 | 19,645.49 | D | — | — | |
| 2 | Common | Common Stock | 2026-04-27 | S | D | 2,817 | $305.20 | 16,828.49 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. |
| 3 | Derivative | Stock Options (Right to Buy) | 2026-04-27 | M | D | 2,817 | $0.00 | 5,635 | D | $83.47 · 2018-02-21 to 2027-02-21 | 2,817 Common Stock | (F2) This award granted on February 21, 2017 vested in four equal annual installments beginning on February 21, 2018. |